Riccardi, Riccardo
 Distribuzione geografica
Continente #
EU - Europa 8.412
NA - Nord America 8.109
AS - Asia 6.210
SA - Sud America 1.374
AF - Africa 139
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 10
Totale 24.286
Nazione #
US - Stati Uniti d'America 7.906
DE - Germania 3.360
SG - Singapore 2.765
CN - Cina 1.895
SE - Svezia 1.180
BR - Brasile 1.175
UA - Ucraina 934
IT - Italia 767
FR - Francia 493
GB - Regno Unito 372
IE - Irlanda 332
IN - India 310
VN - Vietnam 296
FI - Finlandia 267
PL - Polonia 254
ID - Indonesia 222
TR - Turchia 193
RU - Federazione Russa 186
CA - Canada 100
AR - Argentina 86
HK - Hong Kong 81
JP - Giappone 77
IQ - Iraq 74
MX - Messico 71
BD - Bangladesh 66
BE - Belgio 51
NL - Olanda 40
ZA - Sudafrica 34
EC - Ecuador 32
AT - Austria 31
PK - Pakistan 30
ES - Italia 29
AU - Australia 28
UZ - Uzbekistan 27
IR - Iran 22
MA - Marocco 22
KE - Kenya 21
SA - Arabia Saudita 21
CO - Colombia 18
CZ - Repubblica Ceca 18
CL - Cile 14
PE - Perù 13
PY - Paraguay 13
EG - Egitto 12
HU - Ungheria 12
AZ - Azerbaigian 11
CH - Svizzera 11
KZ - Kazakistan 11
VE - Venezuela 11
NP - Nepal 10
RO - Romania 10
IL - Israele 9
JM - Giamaica 9
JO - Giordania 9
KR - Corea 9
LT - Lituania 9
CI - Costa d'Avorio 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
PA - Panama 7
BG - Bulgaria 6
BO - Bolivia 6
DK - Danimarca 6
DZ - Algeria 6
ET - Etiopia 6
EU - Europa 6
GR - Grecia 6
NO - Norvegia 6
AL - Albania 5
HR - Croazia 5
KG - Kirghizistan 5
LK - Sri Lanka 5
NG - Nigeria 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
TH - Thailandia 5
UY - Uruguay 5
BH - Bahrain 4
KW - Kuwait 4
LB - Libano 4
MN - Mongolia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
HN - Honduras 3
LA - Repubblica Popolare Democratica del Laos 3
MY - Malesia 3
OM - Oman 3
PH - Filippine 3
BW - Botswana 2
CY - Cipro 2
GA - Gabon 2
GH - Ghana 2
IS - Islanda 2
Totale 24.255
Città #
Chandler 1.307
Singapore 1.186
Ashburn 814
Jacksonville 585
San Mateo 426
Dublin 329
Beijing 326
Nanjing 282
New York 253
Ann Arbor 238
Jakarta 208
Nürnberg 197
Warsaw 185
Wilmington 183
Dearborn 164
Los Angeles 161
Woodbridge 161
Hangzhou 150
Boston 149
Hefei 134
Moscow 128
Princeton 126
Nanchang 125
Izmir 124
Milan 120
Ho Chi Minh City 110
Munich 104
Houston 101
São Paulo 95
Redwood City 94
Marseille 92
Seattle 91
Rome 89
Fairfield 84
Cattolica 80
Bremen 75
Hong Kong 74
Frankfurt am Main 73
Helsinki 69
Lawrence 69
University Park 65
Dallas 64
Buffalo 63
Hanoi 61
Mountain View 60
Kraków 57
Boardman 56
Lancaster 53
Shenyang 53
Hebei 51
Tokyo 50
Changsha 49
Chicago 46
Tianjin 46
Fremont 45
Kent 44
Brussels 43
Jiaxing 40
Zhengzhou 40
London 38
Leawood 37
Norwalk 35
Rio de Janeiro 34
Santa Clara 34
Shanghai 34
Kunming 33
Pune 32
Chennai 30
Redmond 29
Baghdad 27
Montreal 26
Stockholm 26
Toronto 26
Brasília 25
Brooklyn 24
Cambridge 24
Detroit 24
San Francisco 24
Guangzhou 23
Augusta 22
Belo Horizonte 22
Düsseldorf 21
Nuremberg 21
Orem 21
Porto Alegre 21
Dhaka 20
Denver 19
Tashkent 19
Lauterbourg 18
Nairobi 18
Paris 18
Phoenix 18
Quito 17
Ankara 16
Sanayi 16
Campinas 15
Johannesburg 15
Simi Valley 15
Andover 14
Atlanta 14
Totale 11.312
Nome #
Groshong catheter-related complications in children with cancer 359
Functional Loss of The Inner Retina in Childhood Optic Gliomas Detected by Photopic Negative Response. 301
Platinum compounds in children with cancer: toxicity and clinical management 294
Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial. 253
Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report 245
Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma 243
Complete protection by high-dose dexamethasone against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the rat 223
Variolin B and its derivate deosyvariolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity 217
PRONTUARIO DI TERAPIA PEDIATRICA - Indicazioni terapeutiche, dosaggi ed effetti collaborali dei farmaci nei bambini 203
Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings. 203
Propofol/alfentanil and propofol/ketamine procedural sedation in children with acute lymphoblastic leukaemia: safety, efficacy and their correlation with pain neuromediator expression. 199
The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: a comparative study with SN38 and topotecan. 197
A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas 195
Paediatric Kikuchi-Fujimoto disease: a benign cause of fever and lymphadenopathy. 190
School bullying: an international public health emergency correlated to psychosomatic problems as long-term sequelae 185
Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology 181
Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise? 179
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy. 179
Safe lumbar puncture under analgo-sedation in children with acute lymphoblastic leukemia 174
Expression of liquoral neuroprotection markers in children with acute lymphoblastic leukemia 168
A NEW APPROACH IN THE TREATMENT OF STAGE-IV NEUROBLASTOMA USING A OMBINATION OF {[I-131] METAIODOBENZYLGUANIDINE (MIBG) AND CISPLATIN} 168
Platinum compounds and sodium metabolism in children with diencephalic glioma 168
Vaccine effectiveness against severe laboratory-confirmed influenza in children: results of two consecutive seasons in Italy 168
Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection 164
Comparison between two treatment protocols with recombinant human erythropoietin (rHuEpo) in the treatment of late anemia in neonates with Rh-isoimmunization 163
Femicide and murdered women's children: which future for these children orphans of a living parent? 163
Treatment of advanced neuroblastoma in children over 1 year of age: The critical role of (131) I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen. 162
Extragonadal yolk sac tumor outside of the midline of the body: a case report of a child with a yolk sac tumor of the pontocerebellar angle 162
Intranasal lidocaine and midazolam for procedural sedation in children. 161
Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity. 161
Phase I study of temozolomide combined with oral etoposide in children with malignant glial tumors 154
NGF, DCX AND NSE UPREGOLATION CORRELATES WITH SEVERITY AND OUTCOME OF HEAD TRAUMA IN CHILDREN 152
Anthracycline cardiotoxicity in childhood 152
Current practice and recent advances in pediatric pain management 151
Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to Gefitinib. 150
Cardiac metastases of Ewing sarcoma detected by 18F-FDG PET/CT 149
Hepatic veno-occlusive disease: a chemotherapy-related toxicity in children with malignancies 147
Role of {[I-131]metaiodobeuzylguanidine (MIBG) in the treatment of neuroblastoma: A review} 147
Two cases of pediatric high-grade astroblastoma with different clinical behavior 146
Critical presentation of pleuropulmonary blastoma. 146
Pretreatment neuropsychological deficits in children with brain tumors 145
Feasibility study of 21-day-on/7-day-off temozolomide in children with brain tumors 145
Human parvovirus B 19 and Epstein-Barr virus co-infection in a child with hereditary spherocytosis 145
MRI findings in Scwachman diamond syndrome. 145
Imatinib mesylate potentiates topotecan antitumor activitiy in rhabdomyosarcoma preclinical models 145
A newborn with multiple fractures as first presentation of infantile myofibromatosis 143
Bone mineral density in survivors of childhood brain tumours 143
CLINICAL PHARMACOKINETICS OF CARBOPLATIN IN CHILDREN 143
Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis. 142
Neuropsychological Deterioration Predicts Tumor Progression in a Young Boy With Bithalamic Glioma 141
Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma 140
CYTOTOXICITY OF PACLITAXEL AND DOCETAXEL IN HUMAN NEUROBLASTOMA CELL-LINES 139
Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia 139
Could APC gene screening be useful in children with hepatoblastoma? Early onset of adenocarcinoma in a child with familial adenomatous polyposis and hepatoblastoma 138
Oculogyric crisis in a midbrain lesion. 137
Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma 137
The novel lipophilic camptothecin analogue gimatecan is very active in vitro in human neuroblastoma: a comparative study with SN38 and topotecan. 136
Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology. 136
Intrathecal chemotherapy with antineoplastic agents in children. 135
Safety and efficacy of fentanyl administered by patient controlled analgesia in children with cancer pain. 135
Nerve growth factor eye drop administration improves visual function in a patient with optic glioma 134
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo 134
Phase II trial of temozolomide in children with recurrent high-grade glioma 133
Errors involving patients receiving intrathecal chemotherapy 133
Early reactive neutrophil changes in an infant with Kawasaki syndrome. 132
The role of diet on the clinical pharmacology of oral antineoplastic agents 132
The lumbar puncture in pediatric oncology 132
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma 131
Comparison of propofol versus propofol-ketamine combination in pediatric oncologic procedures performed by non-anesthesiologists. 131
Drug use and upper gastrointestinal complications in children: a case-control study 130
Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models 129
Pretreatment neuropsychological deficits in children with brain tumors 128
Management of children with thrombocytopenia-absent radius syndrome: an institutional experience 126
Efficacy and safety of transdermal buprenorphine in the management of children with cancer-related pain 126
Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia 126
Neutropenia in eta pediatrica 126
Cellular and molecular aspects of drugs of the future: oxaliplatin 125
Nerve growth factor and doublecortin expression correlates with improved outcome in children with severe traumatic brain injury. 125
The unique biologicaql features of the marine product Yondelis (ET-743), trabectedin) are shared by its analog ET-637, which lacks the C ring. 124
Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome 124
Pharmacological management of chemotherapy-induced nausea and vomiting in children with cancer 123
Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukemia 123
Renal toxicity and chemotherapy in children with cancer 123
IL-1 β and IL-6 upregulation in children with H1N1 influenza virus infection 120
I-131 METAIODOBENZYLGUANIDINE IN THE TREATMENT OF NEUROBLASTOMA AT DIAGNOSIS 119
CRITICAL OBSERVATIONS ON NEUROBLASTOMA TREATMENT WITH 131-I-METAIODOBENZYLGUANIDINE AT DIAGNOSIS 118
Stevens-Johnson syndrome in children receiving phenobarbital therapy and cranial radiotherapy. 117
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo. 117
Targeting the mitogen-activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low-grade glioma cells 117
Utility of intranasal Ketamine and Midazolam to perform gastric aspirates in children: a double-blind, placebo controlled, randomized study 116
How to manage vaccinations in children with cancer. 115
A human neuroblastoma xenograft model for 125-I-metaiodobenzylguanidine biodistribution studies 115
Intrathecal chemotherapy with antineoplastic agents in children 115
Incidence, clinical features and management of hypersensitivity reactions to chemotherapeutic drugs in children with cancer 115
Severe acute hypertriglyderidemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis. 114
Phase II trial with temozolomide in children with recurrent high-grade glioma. 114
Central pontine and extrapontine myelinolysis in a pediatric patient following rapid correction of hypernatremia 114
Transdermal buprenorphine in children with cancer-related pain. 113
The ability of mannitol to decrease cisplatin-induced nephrotoxicity in children: real or not? 113
CARBOPLATIN IN CHILDHOOD MEDULLOBLASTOMA PNET - FEASIBILITY OF AN IN-VIVO SENSITIVITY TEST IN AN UP-FRONT STUDY 112
Totale 15.245
Categoria #
all - tutte 97.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.044 0 0 0 0 0 95 216 40 220 123 315 35
2021/20221.890 206 194 26 128 78 69 38 305 82 79 257 428
2022/20233.735 500 535 309 573 216 475 156 309 444 31 123 64
2023/20241.540 80 476 26 107 42 249 84 65 26 52 149 184
2024/20253.434 92 112 223 131 304 136 49 187 658 310 653 579
2025/20265.056 1.414 277 506 1.030 1.502 327 0 0 0 0 0 0
Totale 24.431